The NIH is advancing the development of home-based and point-of-care health technologies with awards to six technology research and development centres across the United States.
UMass Chan Medical School and UMass Lowell have received an $8.9 million award from the National Institutes of Health (NIH) for renewed support of their initiative to advance the development of home-based and point-of-care health technologies. The programme aims to jumpstart new tools to address heart, lung, blood and sleep disorders, especially in underserved populations.
Japan-based Sysmex Corporation recently introduced a testing system in Europe for rapid detection of antimicrobial susceptibility. The system detects the presence or absence of bacteria and assesses the effectiveness of antimicrobials using urine samples from patients suspected of having urinary tract infections (UTIs).
Artificial intelligence (AI) is increasingly used in medicine to improve diagnosis and treatment of diseases, and to avoid unnecessary screening for patients. But AI medical devices could also harm patients and worsen health inequities if they are not designed, tested, and used with care, according to an international task force that included a University of […]
Pursuing fair artificial intelligence (AI) for healthcare requires collaboration between experts across disci-plines, says a global team of scientists led by Duke-NUS Medical School in a new perspective published in npj Digital Medicine.
The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are were published online 25 August 2023 in the European Heart Journal . The document covers the management of unstable angina and all types of acute myocardial infarction.
The European Society of Cardiology (ESC) published Guidelines on cardiomyopathies on 25 August 2023 in European Heart Journal.  This is the first international guideline document to include all cardiomyopathy subtypes, and the first time that specific recommendations are made for cardiomyopathies other than hypertrophic cardiomyopathy.
ESC Congress 2023 Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided PCI, according to research presented at the ESC Congress 2023.
ESC Congress 2023 Pulsed field ablation (PFA) is as effective and safe as conventional thermal ablation for the treatment of paroxysmal atrial fibrillation (AF), according to research presented at ESC Congress 2023.
ESC Congress 2023 Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial infarction survivors with heart failure still an adequate therapy for prevention of sudden cardiac death? The PROFID EHRA trial is set to answer this question in a large, multicentre, EU-funded study. The consortium of partners and colleagues involved in the […]